Table 3.
Impact of BMI on OA related quality of life
| BMI | ||||||||
| =<24.9 | P* | 25–29.9 | p* | >= 30 | ||||
| AIMS2-SF scales | Mean | SD | SD | Mean | Mean | SD | ||
| Lower body | 2.46 | 1.97 | 0.409 | 2.59 | 2.014 | <0.001 | 3.31 | 1.89 |
| Upper body | 1.47 | 2.35 | 0.637 | 1.56 | 2.43 | 0.553 | 1.46 | 2.02 |
| Symptom | 4.55 | 2.25 | 0.158 | 4.80 | 2.15 | 0.029 | 5.31 | 2.17 |
| Affect | 2.66 | 1.31 | 0.073 | 2.85 | 1.27 | <0.001 | 3.22 | 1.42 |
| Social | 4.49 | 1.83 | 0.173 | 4.68 | 1.80 | 0.173 | 4.87 | 1.86 |
| PHQ-9 sum score | 14.32 | 4.59 | 0.165 | 14.85 | 4.44 | 0.002 | 16.67 | 4.93 |
* by means of ANCOVA, adjusted for age, disease duration, Kellgren and Lawrence-score and number of comorbidities for comparing normal vs. overweight and overweight vs. obese